Mobile

An international study to assess the safety and efficacy of a combination of new investigational drugs in hepatitis C virus infected patients with advanced liver disease or require treatment after kid...

Mise à jour : Il y a 4 ans
Référence : EUCTR2014-002121-35

An international study to assess the safety and efficacy of a combination of new investigational drugs in hepatitis C virus infected patients with advanced liver disease or require treatment after kidney transplantation

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The primary objectives of this study are as follows: • To determine the antiviral efficacy of LDV/SOF FDC as measured by the proportion of subjects who attain SVR at 12 weeks after discontinuation of therapy (SVR12) • To evaluate the safety and tolerability of each treatment regimen as assessed by review of the accumulated safety data

Critère d'inclusion

  • Chronic Genotype 1 and Genotype 4 Hepatitis C Virus Infection

Liens